Home Healthcare Biotechnology Rare Biomarkers Specimen Collection and Stabilization Market

Rare Biomarkers Specimen Collection and Stabilization Market Size, Share & Trends Analysis Report By Type (Circulating Cell-Free DNA (ccfDNA), Circulating Tumor Cells (CTCs), Exosomes/Extracellular Vesicles), By Product (Isolation Kits & Reagents, Blood Collection Tubes, Systems), By Application (Non-Invasive Prenatal Testing (NIPT), Oncology, Pharmacogenomics, Transplant Rejection, Cardiovascular Diseases, Others), By End-Users (Hospitals, Perinatal Clinics, Diagnostics Laboratories, Research Institutes, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Dhanashri B | Format: | Report Code: SR6729DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Rare Biomarkers Specimen Collection and Stabilization Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Circulating Cell-Free DNA (ccfDNA)
    2. Circulating Tumor Cells (CTCs)
    3. Exosomes/Extracellular Vesicles
  2. Rare Biomarkers Specimen Collection and Stabilization Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Isolation Kits & Reagents
    2. Blood Collection Tubes
    3. Systems
  3. Rare Biomarkers Specimen Collection and Stabilization Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Non-Invasive Prenatal Testing (NIPT)
    2. Oncology
    3. Pharmacogenomics
    4. Transplant Rejection
    5. Cardiovascular Diseases
    6. Others
  4. Rare Biomarkers Specimen Collection and Stabilization Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Perinatal Clinics
    3. Diagnostics Laboratories
    4. Research Institutes
    5. Others
  5. Regional Rare Biomarkers Specimen Collection and Stabilization Market
    1. North America
      1. North America Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      2. North America Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      3. North America Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      4. North America Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
      5. U.S. Rare Biomarkers Specimen Collection and Stabilization Market
        1. U.S. Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. U.S. Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. U.S. Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. U.S. Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      6. Canada Rare Biomarkers Specimen Collection and Stabilization Market
        1. Canada Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Canada Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Canada Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Canada Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
    2. Europe
      1. Europe Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      2. Europe Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      3. Europe Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      4. Europe Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
      5. U.K. Rare Biomarkers Specimen Collection and Stabilization Market
        1. U.K. Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. U.K. Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. U.K. Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. U.K. Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      6. Germany Rare Biomarkers Specimen Collection and Stabilization Market
        1. Germany Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Germany Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Germany Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Germany Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      7. France Rare Biomarkers Specimen Collection and Stabilization Market
        1. France Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. France Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. France Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. France Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      8. Spain Rare Biomarkers Specimen Collection and Stabilization Market
        1. Spain Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Spain Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Spain Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Spain Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      9. Italy Rare Biomarkers Specimen Collection and Stabilization Market
        1. Italy Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Italy Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Italy Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Italy Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      10. Russia Rare Biomarkers Specimen Collection and Stabilization Market
        1. Russia Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Russia Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Russia Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Russia Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      11. Nordic Rare Biomarkers Specimen Collection and Stabilization Market
        1. Nordic Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Nordic Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Nordic Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Nordic Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      12. Benelux Rare Biomarkers Specimen Collection and Stabilization Market
        1. Benelux Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Benelux Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Benelux Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Benelux Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      13. Rest of Europe Rare Biomarkers Specimen Collection and Stabilization Market
        1. Rest of Europe Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Rest of Europe Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Rest of Europe Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Rest of Europe Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
    3. APAC
      1. APAC Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      2. APAC Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      3. APAC Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      4. APAC Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
      5. China Rare Biomarkers Specimen Collection and Stabilization Market
        1. China Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. China Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. China Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. China Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      6. Korea Rare Biomarkers Specimen Collection and Stabilization Market
        1. Korea Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Korea Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Korea Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Korea Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      7. Japan Rare Biomarkers Specimen Collection and Stabilization Market
        1. Japan Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Japan Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Japan Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Japan Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      8. India Rare Biomarkers Specimen Collection and Stabilization Market
        1. India Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. India Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. India Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. India Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      9. Australia Rare Biomarkers Specimen Collection and Stabilization Market
        1. Australia Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Australia Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Australia Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Australia Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      10. Taiwan Rare Biomarkers Specimen Collection and Stabilization Market
        1. Taiwan Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Taiwan Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Taiwan Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Taiwan Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      11. South East Asia Rare Biomarkers Specimen Collection and Stabilization Market
        1. South East Asia Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. South East Asia Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. South East Asia Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. South East Asia Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      12. Rest of Asia-Pacific Rare Biomarkers Specimen Collection and Stabilization Market
        1. Rest of Asia-Pacific Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Rest of Asia-Pacific Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Rest of Asia-Pacific Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Rest of Asia-Pacific Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
    4. Middle East and Africa
      1. Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      2. Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      3. Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      4. Middle East and Africa Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
      5. UAE Rare Biomarkers Specimen Collection and Stabilization Market
        1. UAE Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. UAE Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. UAE Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. UAE Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      6. Turkey Rare Biomarkers Specimen Collection and Stabilization Market
        1. Turkey Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Turkey Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Turkey Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Turkey Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      7. Saudi Arabia Rare Biomarkers Specimen Collection and Stabilization Market
        1. Saudi Arabia Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Saudi Arabia Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Saudi Arabia Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Saudi Arabia Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      8. South Africa Rare Biomarkers Specimen Collection and Stabilization Market
        1. South Africa Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. South Africa Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. South Africa Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. South Africa Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      9. Egypt Rare Biomarkers Specimen Collection and Stabilization Market
        1. Egypt Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Egypt Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Egypt Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Egypt Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      10. Nigeria Rare Biomarkers Specimen Collection and Stabilization Market
        1. Nigeria Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Nigeria Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Nigeria Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Nigeria Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      11. Rest of MEA Rare Biomarkers Specimen Collection and Stabilization Market
        1. Rest of MEA Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Rest of MEA Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Rest of MEA Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Rest of MEA Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
    5. LATAM
      1. LATAM Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
        1. Circulating Cell-Free DNA (ccfDNA)
        2. Circulating Tumor Cells (CTCs)
        3. Exosomes/Extracellular Vesicles
      2. LATAM Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
        1. Isolation Kits & Reagents
        2. Blood Collection Tubes
        3. Systems
      3. LATAM Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
        1. Non-Invasive Prenatal Testing (NIPT)
        2. Oncology
        3. Pharmacogenomics
        4. Transplant Rejection
        5. Cardiovascular Diseases
        6. Others
      4. LATAM Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Perinatal Clinics
        3. Diagnostics Laboratories
        4. Research Institutes
        5. Others
      5. Brazil Rare Biomarkers Specimen Collection and Stabilization Market
        1. Brazil Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Brazil Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Brazil Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Brazil Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      6. Mexico Rare Biomarkers Specimen Collection and Stabilization Market
        1. Mexico Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Mexico Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Mexico Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Mexico Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      7. Argentina Rare Biomarkers Specimen Collection and Stabilization Market
        1. Argentina Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Argentina Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Argentina Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Argentina Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      8. Chile Rare Biomarkers Specimen Collection and Stabilization Market
        1. Chile Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Chile Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Chile Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Chile Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      9. Colombia Rare Biomarkers Specimen Collection and Stabilization Market
        1. Colombia Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Colombia Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Colombia Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Colombia Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
      10. Rest of LATAM Rare Biomarkers Specimen Collection and Stabilization Market
        1. Rest of LATAM Rare Biomarkers Specimen Collection and Stabilization Market By Type 2022-2034 (USD MILLION/ Units)
          1. Circulating Cell-Free DNA (ccfDNA)
          2. Circulating Tumor Cells (CTCs)
          3. Exosomes/Extracellular Vesicles
        2. Rest of LATAM Rare Biomarkers Specimen Collection and Stabilization Market By Product 2022-2034 (USD MILLION/ Units)
          1. Isolation Kits & Reagents
          2. Blood Collection Tubes
          3. Systems
        3. Rest of LATAM Rare Biomarkers Specimen Collection and Stabilization Market By Application 2022-2034 (USD MILLION/ Units)
          1. Non-Invasive Prenatal Testing (NIPT)
          2. Oncology
          3. Pharmacogenomics
          4. Transplant Rejection
          5. Cardiovascular Diseases
          6. Others
        4. Rest of LATAM Rare Biomarkers Specimen Collection and Stabilization Market By End-Users 2022-2034 (USD MILLION/ Units)
          1. Hospitals
          2. Perinatal Clinics
          3. Diagnostics Laboratories
          4. Research Institutes
          5. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.